Unwanted facial hair: affects, effects and solutions.
The following is a review of a satellite symposium held at the EHRS Meeting in June 2006. U.B.P. reminded the audience that unwanted facial hair (UFH) is an important issue; over 40% of the women in the general population have some degree of UFH, and its psychological and psychosocial impact should not be underestimated. The treatment of UFH involves many different disciplines, and the symposium offered the latest thinking in different aspects of the disorder. S.L. outlined the current concepts surrounding polycystic ovarian syndrome, and U.G. addressed the psychological aspects of UFH. J.S. described the current treatment options for UFH, followed by U.B.P.'s evidence-based therapy review. Finally, R.H. reviewed the latest trial results with Trichoscan, a method being investigated for assessing UFH removal.
Blume-Peytavi
U
U
Department of Dermatology and Allergy, Center of Experimental and Applied Cutaneous Physiology (CCP), Charité-Universitatsmedizin Berlin, Berlin, Germany.
Gieler
U
U
Hoffmann
R
R
Lavery
S
S
Shapiro
J
J
D000726:Androgen Antagonists / Q000627:therapeutic use; D003863:Depression / Q000209:etiology; D004333:Drug Administration Routes; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005145:Face; D005260:Female; D006204:Hair Removal / Q000295:instrumentation / Q000379:methods*; D006628:Hirsutism / Q000209:etiology / Q000523:psychology / Q000628:therapy; D006801:Humans; D053685:Laser Therapy / Q000379:methods; D011085:Polycystic Ovary Syndrome / Q000150:complications* / Q000188:drug therapy; D011788:Quality of Life
D000726:Androgen Antagonists; D004791:Enzyme Inhibitors